RT Journal Article
SR Electronic
T1 Mitigating the impact of COVID-19 on tuberculosis and HIV services: a cross-sectional survey of 669 health professionals in 64 low and middle-income countries
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.08.20207969
DO 10.1101/2020.10.08.20207969
A1 Mishal S. Khan
A1 Sonia Rego
A1 Joaquín Benítez Rajal
A1 Virginia Bond
A1 Razia Kaneez Fatima
A1 Afshan Khurshid Isani
A1 Jayne Sutherland
A1 Katharina Kranzer
YR 2020
UL http://medrxiv.org/content/early/2020/10/13/2020.10.08.20207969.abstract
AB Objective The experiences of frontline healthcare professionals are essential in identifying strategies to mitigate the disruption to healthcare services caused by the COVID-19 pandemic.Methods We conducted a cross-sectional study of TB and HIV professionals in low and middle-income countries (LMIC). Between May 12 and August 6 2020, we collected qualitative and quantitative data using an online survey in 11 languages. We used descriptive statistics and thematic analysis to analyse responses.Findings 669 respondents from 64 countries completed the survey. Over 40% stated that it was either impossible or much harder for TB and HIV patients to reach healthcare facilities since COVID-19. The most common barriers reported to affect patients were: fear of getting infected with SARS-CoV-2, transport disruptions and movement restrictions. 37% and 28% of responses about TB and HIV stated that healthcare provider access to facilities was also severely impacted. Strategies to address reduced transport needs and costs – including proactive coordination between the health and transport sector and cards that facilitate lower cost or easier travel - were presented in qualitative responses. Access to non-medical support for patients, such as food supplementation or counselling, was severely disrupted according to 36% and 31% of HIV and TB respondents respectively; qualitative data suggested that the need for such services was exacerbated.Conclusion Patients and healthcare providers across numerous LMIC faced substantial challenges in accessing healthcare facilities, and non-medical support for patients was particularly impacted. Synthesising recommendations of frontline professionals should be prioritised for informing policymakers and healthcare service delivery organisations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMSK received funding from the Wellcome/LSHTM Institutional Strategic Support Fund (ISSF) partnership grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics review committees from the following institutions approved this study: the London School of Hygiene and Tropical Medicine, the University of Zambia and The South African Medical AssociationAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData about responses from individual countries cannot be shared publicly because small numbers of responses from certain countries lead to the risk of respondents being identifiable. We are committed to sharing data in line with the rules of our ethical approval. Data are available from the corresponding author for researchers who meet the criteria for access to confidential data.